Global Respiratory Disease Testing Market 2015-2019

NEW YORK, Nov. 17, 2015 /PRNewswire/ -- About respiratory disease testing
The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system. The respiratory testing devices help in detecting chronic or acute respiratory diseases; therefore, the necessary treatment can be provided to people suffering from respiratory damages.

Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. This indicates an alarming increase in the respiratory disorders worldwide due to high pollution and increased tobacco consumption.
These factors result in increased demand for the respiratory testing devices and propel the market growth.

Technavio's analysts forecast the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases.

The market is segmented based on the type of test:
Mechanical/screening tests
- Spirometry test
- Peak flow test
- Blood gas test
- Lung volume test
- OSA diagnostic tests
IVD tests
- Molecular diagnostic test
- POC test
- Others

Technavio's report, Global Respiratory Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key vendors
- Alere
- CareFusion
- Nihon Kohden
- Philips Healthcare
- Smiths Medical

Other prominent vendors
- Abbott
- Affymetrix
- Cepheid
- COSMED
- Covidien
- F. Hoffmann-La Roche
- Futuremed America
- Instrumentation Laboratories
- ndd Medical Technology
- SDI Diagnostics
- Seegene
- Siemens Healthcare

Key market driver
- Increase in respiratory disorders worldwide
- For a full, detailed list, view our report

Key market challenge
- Use of low-cost testing products
- For a full, detailed list, view our report

Key market trend
- Initiatives and programs to create awareness
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Read the full report: http://www.reportlinker.com/p03391421-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com